drugset / Trial / NCT04498715

Trochanteric Femur Fracture Operated With Dynamic Hip Screw System (DHS) Augmented With a Biphasic Apatite Sulphate Combined With Systemic or Local Bisphosphonate

NCT04498715

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to study the process of bone regeneration around a metal device in the femoral neck canal using a synthetic bone substitute Cerament bone void filler (BVF) and bisphosphonate (Zometa) locally or systemically that affects bone metabolism. Furthermore, fracture healing and implant migration will be investigated.

Timeline

Start
2021-06-01
Primary completion
2024-06
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Zoledronic acid Other / unclassified 1 mg Intravenous
Subject Zoledronic acid Other / unclassified 2 mg Intravenous
Subject Zoledronic acid Other / unclassified 4 mg Intravenous

Indications

No indication recorded.